Literature DB >> 20038266

Development of mucoadhesive poly(lactide-co-glycolide) nanoparticles for ocular application.

Krassimira Yoncheva1, Jo Vandervoort, Annick Ludwig.   

Abstract

Pilocarpine loaded poly(lactic-co-glycolic acid) (PLGA) nanoparticles were prepared by solvent evaporation method and coated with various mucoadhesive polymers, in particular chitosan, sodium alginate and poloxamers. The size of chitosan-coated nanoparticles was larger than the size of all the other particles obtained. Their surface charge was changed from negative (-22.8 mV) to positive (+61.0 mV). The interaction between mucin and chitosan-coated nanoparticles took place up to six hours according to turbidimetric study. The positive charge of chitosan-coated nanoparticles decreased significantly six hours after incubation in mucin dispersion, which was attributed to their electrostatic interaction. The coating with chitosan could be considered useful approach aiming to prolong nanoparticle residence time after local ocular application.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20038266     DOI: 10.3109/10837450903479954

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  12 in total

Review 1.  Nanomedicine in the application of uveal melanoma.

Authors:  Shuo You; Jing Luo; Hans E Grossniklaus; Ma-Ling Gou; Ke Meng; Qing Zhang
Journal:  Int J Ophthalmol       Date:  2016-08-18       Impact factor: 1.779

2.  Nanogels of methylcellulose hydrophobized with N-tert-butylacrylamide for ocular drug delivery.

Authors:  Marion Jamard; Todd Hoare; Heather Sheardown
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

Review 3.  Nanoparticles for drug delivery to the anterior segment of the eye.

Authors:  Dileep R Janagam; Linfeng Wu; Tao L Lowe
Journal:  Adv Drug Deliv Rev       Date:  2017-04-06       Impact factor: 15.470

4.  Biodegradable PLGA-Based Drug Delivery Systems for Modulating Ocular Surface Disease under Experimental Murine Dry Eye.

Authors:  Emmanuel Chang; Andrew J McClellan; William J Farley; De-Quan Li; Stephen C Pflugfelder; Cintia S De Paiva
Journal:  J Clin Exp Ophthalmol       Date:  2011-11-06

5.  Development and in vitro Evaluation of Voriconazole Nanoparticle Formulation for Mucosal Application.

Authors:  Seda Rençber; Sinem Yaprak Karavana
Journal:  Turk J Pharm Sci       Date:  2018-07-17

6.  Preparation and In Vitro/Ex Vivo Evaluation of Moxifloxacin-Loaded PLGA Nanosuspensions for Ophthalmic Application.

Authors:  Meetali Mudgil; Pravin K Pawar
Journal:  Sci Pharm       Date:  2013-02-04

7.  Development, characterization, and in vivo assessment of mucoadhesive nanoparticles containing fluconazole for the local treatment of oral candidiasis.

Authors:  Seda Rençber; Sinem Yaprak Karavana; Fethiye Ferda Yılmaz; Bayri Eraç; Merve Nenni; Seda Özbal; Çetin Pekçetin; Hande Gurer-Orhan; Mine Hoşgör-Limoncu; Pelin Güneri; Gökhan Ertan
Journal:  Int J Nanomedicine       Date:  2016-06-10

8.  Low Molecular Weight Chitosan-Coated PLGA Nanoparticles for Pulmonary Delivery of Tobramycin for Cystic Fibrosis.

Authors:  Nusaiba K Al-Nemrawi; Nid''A H Alshraiedeh; Aref L Zayed; Bashar M Altaani
Journal:  Pharmaceuticals (Basel)       Date:  2018-03-08

Review 9.  Advanced drug delivery and targeting technologies for the ocular diseases.

Authors:  Jaleh Barar; Ayuob Aghanejad; Marziyeh Fathi; Yadollah Omidi
Journal:  Bioimpacts       Date:  2016-03-30

10.  Solutol HS15 based binary mixed micelles with penetration enhancers for augmented corneal delivery of sertaconazole nitrate: optimization, in vitro, ex vivo and in vivo characterization.

Authors:  Nihal Farid Younes; Sally Adel Abdel-Halim; Abdelhalim I Elassasy
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.